COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide)
ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) — Covis Pharma Group (the “Company”), a global…